Zhongnan Medical Journal Press

Home Results

A total of 10 result was found. Results that relate to WANG Yi

Multicenter retrospective investigation and analysis of the rationality of the application of human albumin in cardiac surgery during the perioperative period

Published on Chinese Journal of Pharmacoepidemiology 2024,33(2):176-183.
1559 times 848 times

PAN Wenfei YU Huan DANG Dasheng CHEN Lijuan LI Te SHI Tianlu HUANG Banghua LI Boxia GONG Xiaoxue WANG Ying

Human serum albumin Clinical application Retrospective study Rational drug use
Details
Distribution characteristics and drug resistance of 267 strains in intensive care unit

Published on Frontiers in Pharmaceutical Sciences 2024,27(5):848-854.
2068 times 491 times

XIE Qiyang WANG Yi LOU Yanming LOU Hanjian HE Junhong

Intensive care unit Hospital acquired infection Pathogenic bacteria distribution Antimicrobial drugs Drug resistance Drug susceptitle test
Details
Application of simulation courses in the teaching of ultrasound-guided regional anaesthesia among residents

Published on Journal of Mathematical Medicine 2024,37(7):555-560.
2004 times 462 times

ZHENG Qihui LIU Wei JIN Xuelei WANG Yingbin WANG Yuanjie

Ultrasound-guided regional anaesthesia Simulation training Residents Education
Details
Clinical study of atorvastatin combined with colchicine for in-stent restenosis after percutaneous coronary intervention

Published on Frontiers in Pharmaceutical Sciences 2024,28(1):65-72.
2198 times 357 times

WANG Jun YANG Xiaoyu HUNAG Zurong WEI Kun ZHANG Yuelong WANG Ying

Atorvastatin calcium tablets Colchicine In stent restenosis Percutaneous coronary intervention Acute coronary syndrome Major adverse cardiovascular events
Details
Signal mining and analysis of adverse events of four LAMA drugs based on the FAERS database

Published on Chinese Journal of Pharmacoepidemiology 2024,33(10):1081-1090.
2925 times 492 times

QIN Honghua GUO Haiyan YANG Liu WANG Ying TONG Xiaona LI Haifeng

Aclidinium bromide Glycopyrronium bromide Umeclidinium bromide Tiotropium bromide Adverse drug event Signal mining Pharmacovigilance FAERS database
Details
Research progress on processing technology, chemical constituents and pharmacological activities of Polygoni multiflori radix praeparata

Published on Frontiers in Pharmaceutical Sciences 2024,28(3):523-535.
2408 times 369 times

YAO Rui GUO Hong ZHANG Xiaoshu WANG Ying GUO Xiaohan CHEN Jia LI Jinhao XU Ling YANG Jianbo JING Wenguang CHENG Xianlong WEI Feng

Polygoni multiflori radix praeparata Processing technology Chemical constituents Stilbene glycosides Anthraquinones Flavonoids Alkaloids Phenolic acids Pharmacological activity Antioxidant Antianemic Anti-tumor Hypoglycemic Anti- inflammatory
Details
Current status analysis of anti-infection research by using the Bayesian method

Published on Chinese Journal of Pharmacoepidemiology 2025,34(1):69-77.
1289 times 185 times

LIU Yiling LIU Jinglin LU Zhenzhen WANG Yingying JIANG Qijing LI Bingzhe DAI Luyan YAN Fanrong HUANG Lihong

Bayesian method Anti-infection research Research features
Details
Research on the design space of extraction process for Folium stevia formula granules based on consistency with standard decoction

Published on Frontiers in Pharmaceutical Sciences 2025,29(1):40-49.
1336 times 146 times

WU Meilan WANG Yifang SUN Xiaoming SUN Lien

Folium stevia Formula granules Standard decoction Analytic hierarchy process method Entropy weight method Box-Behnken design Design space
Details
Signals mining and analysis of adverse drug events in minors using recombinant human growth hormone based on the FAERS database

Published on Chinese Journal of Pharmacoepidemiology 2025,34(2):157-165.
1132 times 141 times

DONG Jiaxiao WANG Yilei LI Xiuzheng LI Jie XU Yichun XU Xiaodong

Recombinant human growth hormone Data mining Adverse drug events Minors Pharmacovigilance
Details
Prediction of antibacterial mechanism of Xiaoyan Kangjun tablets based on network pharmacology and molecular docking

Published on Frontiers in Pharmaceutical Sciences 2025,29(2):181-191.
824 times 131 times

JIN Dan SHEN Bingzheng WANG Yingyin ZHOU Benhong

Xiaoyan Kangjun tablets Network pharmacology Target Antibacterial Anti-inflammatory Molecular docking
Details